Cerner Corp. (NASDAQ:CERN) has been given a $63.00 price objective by Barclays PLC in a research note issued to investors on Monday. The brokerage presently has a “buy” rating on the stock. Barclays PLC’s price objective would suggest a potential upside of 25.85% from the company’s previous close.

A number of other analysts have also weighed in on the stock. Bank of America Corp. lowered shares of Cerner Corp. from a “neutral” rating to an “underperform” rating in a report on Monday, November 7th. Canaccord Genuity reaffirmed a “buy” rating and set a $68.00 target price on shares of Cerner Corp. in a report on Sunday, September 11th. Vetr lowered shares of Cerner Corp. from a “hold” rating to a “sell” rating and set a $64.78 target price on the stock. in a report on Monday, August 8th. Stifel Nicolaus initiated coverage on shares of Cerner Corp. in a report on Wednesday, August 31st. They set a “hold” rating on the stock. Finally, Piper Jaffray Cos. reaffirmed an “overweight” rating and set a $81.00 target price on shares of Cerner Corp. in a report on Monday, August 29th. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $64.88.

Analyst Recommendations for Cerner Corp. (NASDAQ:CERN)

Cerner Corp. (NASDAQ:CERN) opened at 50.06 on Monday. Cerner Corp. has a one year low of $48.04 and a one year high of $67.50. The stock’s 50 day moving average is $56.09 and its 200-day moving average is $59.11. The firm has a market cap of $17.00 billion, a price-to-earnings ratio of 26.47 and a beta of 1.11.

Cerner Corp. (NASDAQ:CERN) last posted its earnings results on Tuesday, November 1st. The company reported $0.59 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.60 by $0.01. The firm had revenue of $1.19 billion for the quarter, compared to the consensus estimate of $1.24 billion. Cerner Corp. had a return on equity of 18.39% and a net margin of 13.85%. The business’s revenue was up 5.1% on a year-over-year basis. During the same period last year, the company posted $0.54 EPS. On average, equities research analysts expect that Cerner Corp. will post $2.30 earnings per share for the current fiscal year.

In other Cerner Corp. news, Director Linda M. Dillman sold 6,000 shares of the firm’s stock in a transaction dated Tuesday, September 6th. The shares were sold at an average price of $64.68, for a total transaction of $388,080.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William D. Zollars sold 10,000 shares of the firm’s stock in a transaction dated Monday, November 7th. The shares were sold at an average price of $51.50, for a total transaction of $515,000.00. The disclosure for this sale can be found here. Company insiders own 13.20% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the stock. Johnson Financial Group Inc. raised its stake in Cerner Corp. by 37.8% in the second quarter. Johnson Financial Group Inc. now owns 1,882 shares of the company’s stock worth $111,000 after buying an additional 516 shares in the last quarter. Mycio Wealth Partners LLC raised its stake in Cerner Corp. by 33.5% in the second quarter. Mycio Wealth Partners LLC now owns 1,997 shares of the company’s stock worth $117,000 after buying an additional 501 shares in the last quarter. Fuller & Thaler Asset Management Inc. purchased a new stake in Cerner Corp. during the third quarter worth $124,000. Alpha Windward LLC raised its stake in Cerner Corp. by 2.2% in the second quarter. Alpha Windward LLC now owns 2,061 shares of the company’s stock worth $121,000 after buying an additional 44 shares in the last quarter. Finally, NN Investment Partners Holdings N.V. raised its stake in Cerner Corp. by 16.8% in the second quarter. NN Investment Partners Holdings N.V. now owns 2,085 shares of the company’s stock worth $122,000 after buying an additional 300 shares in the last quarter. Institutional investors and hedge funds own 82.78% of the company’s stock.

WARNING: This piece was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another website, it was illegally stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2016/11/23/cerner-corp-cern-given-a-63-00-price-target-by-barclays-plc-analysts.html.

About Cerner Corp.

Cerner Corporation is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations. Its segments include Domestic and Global. The Domestic segment includes the business activity in the United States.

5 Day Chart for NASDAQ:CERN

Receive News & Stock Ratings for Cerner Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Corp. and related stocks with our FREE daily email newsletter.